Information:
Fel:
ID
16595
Beskrivning
MIPSO Comparative study of bacterial microbiota in the skin and intestines of psoriasis patients before and after systemic treatment with adalimumab or ustekinumab or ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. H. C. Thomas A. Luger
Nyckelord
Versioner (2)
- 2015-12-08 2015-12-08 -
- 2016-07-25 2016-07-25 -
Uppladdad den
25 juli 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
End of Study Psoriasis MIPSO EudraCT 2014-003022-40 DRKS00007147
End of Study Psoriasis MIPSO EudraCT 2014-003022-40
- StudyEvent: ODM
Similar models
End of Study Psoriasis MIPSO EudraCT 2014-003022-40
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Patient number
Item
text
C1830427 (UMLS CUI [1])
Date end of study
Item
date
C2983670 (UMLS CUI [1])
CL Item
regular end of study (1)
CL Item
early study termination (2)
CL Item
Change of treatment required (1)
CL Item
Patient's request (2)
CL Item
Inclusion/exclusion criteria were injured, before initializing therapy (3)
CL Item
Inclusion/exclusion criteria were injured, after initializing therapy (4)
CL Item
Entering pregnancy (5)
CL Item
Disallowed concomitant medication required (6)
CL Item
The continued participation in the clinical trial is medically no longer justifiable (7)
CL Item
Time windows for visits could not be complied with (8)
CL Item
Lack of patient compliance (9)
CL Item
Cancelation of the entire study (10)
CL Item
other reason (11)
End of Study Reason
Item
text
C0444496 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])